These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 20473253

  • 41. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
    Kanno Y, Nemoto H, Nakamoto H, Okada H, Sugahara S, Nishidome K, Yamashita Y, Suzuki H.
    J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
    [Abstract] [Full Text] [Related]

  • 42. Soluble vascular endothelial-cadherin levels in patients with sepsis treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
    Ebihara I, Hirayama K, Nagai M, Koda M, Gunji M, Okubo Y, Katayama T, Sato C, Usui J, Yamagata K, Kobayashi M.
    Ther Apher Dial; 2014 Jun; 18(3):272-8. PubMed ID: 24965294
    [Abstract] [Full Text] [Related]

  • 43. Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism.
    Kushi H, Miki T, Sakagami Y, Saito T, Tanjoh K.
    Ther Apher Dial; 2008 Aug; 12(4):292-7. PubMed ID: 18789116
    [Abstract] [Full Text] [Related]

  • 44. Effect of hemoperfusion using polymyxin B-immobilized fiber on IL-6, HMGB-1, and IFN gamma in a neonatal sepsis model.
    Hussein MH, Kato T, Sugiura T, Daoud GA, Suzuki S, Fukuda S, Sobajima H, Kato I, Togari H.
    Pediatr Res; 2005 Aug; 58(2):309-14. PubMed ID: 16006426
    [Abstract] [Full Text] [Related]

  • 45. Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients.
    Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Maeda S, Yamagishi S.
    J Crit Care; 2011 Dec; 26(6):546-9. PubMed ID: 21273029
    [Abstract] [Full Text] [Related]

  • 46. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column.
    Huang Z, Wang SR, Su W, Liu JY.
    Ther Apher Dial; 2010 Dec; 14(6):596-602. PubMed ID: 21118369
    [Abstract] [Full Text] [Related]

  • 47. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation.
    Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K.
    Crit Care; 2005 Dec; 9(6):R653-61. PubMed ID: 16280061
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Effects of polymyxin B-immobilized fiber hemoperfusion on amino acid imbalance in septic encephalopathy.
    Nakamura T, Kawagoe Y, Matsuda T, Ebihara I, Koide H.
    Blood Purif; 2003 Dec; 21(4-5):282-6. PubMed ID: 12944727
    [Abstract] [Full Text] [Related]

  • 53. Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study.
    Mitaka C, Kusao M, Kawagoe I, Satoh D, Iba T, Ronco C.
    Blood Purif; 2022 Dec; 51(1):62-69. PubMed ID: 33910191
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.